| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | +55.7% |
| Cost of Revenue | $853K | +30.4% |
| Gross Profit | $1.0M | +86.3% |
| R&D Expense | $1.7M | +39.4% |
| SG&A Expense | $5.5M | -21.3% |
| Operating Income | -$6.2M | +19.2% |
| Interest Expense | $22K | +450.0% |
| Net Income | -$6.2M | +19.8% |
| EPS (Basic) | -$8.86 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.3M | -75.8% |
| Accounts Receivable | $335K | +252.6% |
| Inventory | $794K | -0.1% |
| Current Assets | $2.8M | -57.8% |
| Total Assets | $3.3M | -55.1% |
| Current Liabilities | $561K | -28.6% |
| Total Liabilities | $767K | -18.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.0M | +20.3% |
| Capital Expenditures | $84K | -43.6% |
| Investing Cash Flow | -$56K | +62.4% |
| Financing Cash Flow | $2.0M | -76.0% |
| Free Cash Flow | -$6.1M | +20.7% |
| +23.0% |
| EPS (Diluted) | -$8.86 | +23.0% |
| Stockholders' Equity |
| $2.5M |
| -60.5% |